Most breast cancer patients return to working same hours

July 12, 2012
Most breast cancer patients return to working same hours
Nearly three-quarters of women treated for breast cancer return to their prediagnosis working time, according to a study published online July 9 in the Journal of Clinical Oncology.

(HealthDay) -- Nearly three-quarters of women treated for breast cancer return to their prediagnosis working time, according to a study published online July 9 in the Journal of Clinical Oncology.

To examine changes in working time 16 months after a breast cancer diagnosis, Marie Høyer, R.N., from the Uppsala University Hospital in Sweden, and colleagues identified patients with breast cancer using the Regional Breast Cancer Quality Register of Central Sweden. Questionnaires were completed at baseline and follow-up (average of four and 16 months after diagnosis) by 505 (younger than 63 years at diagnosis).

Compared with prediagnosis working time, at follow-up the researchers found that 72 percent reported no change, 2 percent reported an increase, 15 percent reported a decrease, and 11 percent did not work. The likelihood of job discontinuation/decreased working time was increased for patients undergoing chemotherapy (odds ratio [OR], 2.45). For chemotherapy recipients, full-time work prediagnosis (OR, 3.25), cancer-related work limitations (OR, 5.26), and less value attached to work (OR, 3.69) correlated with decreased working time. Among not receiving chemotherapy, older age (OR, 1.09) and less value attached to work (OR, 5.00) correlated with decreased working time.

"Chemotherapy and cancer-related work limitations are important factors to take into account to identify women in need of support," the authors write. "It is also essential to consider that a diagnosis may be followed by a reassessment of life goals. Thus, not returning to work or decreasing working time may be the optimal outcome for some women."

Explore further: Gene expression profile testing increasing in breast cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gene expression profile testing increasing in breast cancer

May 18, 2012
(HealthDay) -- From 2006 to 2008, the use of gene expression profile (GEP) testing increased, correlating with a decrease in the percentage of women with hormone receptor (HR)-positive breast cancer receiving adjuvant chemotherapy, ...

Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients

July 18, 2011
The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.

Weight gain linked to hot flashes after breast cancer

March 21, 2012
(HealthDay) -- Early-stage breast cancer survivors who gain at least 10 percent of their pre-diagnosis weight are significantly more likely to report hot flashes than those who remain weight stable, according to a study published ...

Breast cancer survivors struggle with cognitive problems several years after treatment

December 12, 2011
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation ...

Higher incidence of secondary breast cancer seen among black women regardless of age

September 19, 2011
The overall incidence of breast cancer is generally higher among white women than black women; however, the incidence of a second breast cancer in the opposite breast is higher among black women, according to a study presented ...

Breast cancer type linked to paternal cancer

November 28, 2011
The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.